Cancer Family
Malignant Respiratory System Neoplasm
CI-CAN-00000249Explore in graph →
2,650 active trials51 approved drugs619 evidence items
- NCIt
- C4571
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000249Explore in graph →
Clinical trials
11,130 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,492)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00950365 | Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 | 79 | Albert Einstein College of MedicineOTHER | 1 | Sep 16, 2020 | clinicaltrials |
| NCT01331863 | Airway and/or Pulmonary Vessels Transplantation(TRACHBRONCAR) | completed | Phase 1 / Phase 2 | 16 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 9, 2020 |
| clinicaltrials |
| NCT03450330 | Assessing an Oral Janus Kinase Inhibitor, AZD4205, in Combination With Osimertinib in Patients Who Have Advanced Non-small Cell Lung Cancer(JACKPOT1) | completed | Phase 1 / Phase 2 | 10 | Dizal PharmaceuticalsINDUSTRY | 1 | Aug 24, 2020 | clinicaltrials |
| NCT00547105 | Erlotinib and SBRT in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer | completed | Phase 2 | 24 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 21, 2020 | clinicaltrials |
| NCT02499770 | Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) | completed | Phase 1 / Phase 2 | 122 | G1 Therapeutics, Inc.INDUSTRY | 7 | Aug 21, 2020 | clinicaltrials |
| NCT01218516 | A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung | completed | Phase 2 | 130 | MorphotekINDUSTRY | 8 | Aug 20, 2020 | clinicaltrials |
| NCT00006469 | Combination Chemotherapy and Radiation Therapy Followed By Surgery in Treating Patients With Stage IIB or Stage IIIA Non-Small Cell Lung Cancer | completed | Phase 2 | 30 | Medstar Health Research InstituteOTHER | 1 | Aug 19, 2020 | clinicaltrials |
| NCT03086733 | Phase II Lung Metcore - Preoperative Metformin for Lung Cancer(Metcore) | completed | Phase 2 | 28 | University Health Network, TorontoOTHER | 1 | Aug 19, 2020 | clinicaltrials |
| NCT02492568 | Pembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLC(PEMBRO-RT) | completed | Phase 2 | 92 | The Netherlands Cancer InstituteOTHER | 1 | Aug 17, 2020 | clinicaltrials |
| NCT01833143 | Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12D | completed | Phase 2 | 17 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 4, 2020 | clinicaltrials |
| NCT00020878 | Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers | completed | Phase 2 | 21 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT00024076 | Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer | completed | Phase 2 | 30 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT00062179 | Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer | completed | Phase 2 | 7 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT02490696 | Comparative Study of the Hypoxia Measured in FAZA and F-miso PET/CT Scan in Patients With Non-small Cell Lung Cancer(RTEP6) | completed | Phase 2 | 23 | Centre Henri BecquerelOTHER | 1 | Jul 30, 2020 | clinicaltrials |
| NCT00278148 | Erlotinib, Paclitaxel, and Carboplatin Combined With Radiation Therapy for Stage III Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 32 | Nathan Pennell, MD, PhDOTHER | 1 | Jul 20, 2020 | clinicaltrials |
| NCT01636934 | Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy | completed | Phase 2 | 51 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 17, 2020 | clinicaltrials |
| NCT03183232 | Safety and Efficiency of γδ T Cell Against Lung Cancer | completed | Phase 1 / Phase 2 | 30 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jul 13, 2020 | clinicaltrials |
| NCT00866970 | Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia | completed | Phase 2 | 124 | CSL BehringINDUSTRY | 9 | Jul 9, 2020 | clinicaltrials |
| NCT00530621 | Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung Cancer | completed | Phase 2 | 160 | Eli Lilly and CompanyINDUSTRY | 6 | Jul 1, 2020 | clinicaltrials |
| NCT01941654 | ATOM_local Ablative Therapy | completed | Phase 2 | 18 | Chinese University of Hong KongOTHER | 1 | Jun 18, 2020 | clinicaltrials |
| NCT01101334 | Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 90 | Daiichi SankyoINDUSTRY | 4 | Jun 16, 2020 | clinicaltrials |
| NCT00073398 | Vaccine Treatment for Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 54 | NewLink Genetics CorporationINDUSTRY | 1 | May 28, 2020 | clinicaltrials |
| NCT01380769 | A Phase 2 Study of CRLX101(NLG207) in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 157 | NewLink Genetics CorporationINDUSTRY | 2 | May 28, 2020 | clinicaltrials |
| NCT00915005 | Trial of Image-Guided Adaptive Conformal Photon vs Proton Therapy, With Concurrent Chemotherapy, for Locally Advanced Non-Small Cell Lung Carcinoma: Treatment Related Pneumonitis and Locoregional Recurrence | completed | Phase 2 | 275 | M.D. Anderson Cancer CenterOTHER | 1 | May 26, 2020 | clinicaltrials |
| NCT03472053 | A Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 60 | BioMarck Pharmaceuticals, Ltd.INDUSTRY | 1 | May 19, 2020 | clinicaltrials |
| NCT00002586 | 13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer(13-Cis) | completed | Phase 2 | 96 | University of Colorado, DenverOTHER | 1 | May 15, 2020 | clinicaltrials |
| NCT00084409 | Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease | completed | Phase 2 | 152 | University of Colorado, DenverOTHER | 1 | May 14, 2020 | clinicaltrials |
| NCT02289690 | Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 221 | AbbVieINDUSTRY | 12 | May 14, 2020 | clinicaltrials |
| NCT00806286 | Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer | completed | Phase 2 | 111 | Daiichi SankyoINDUSTRY | 4 | May 13, 2020 | clinicaltrials |
| NCT01671332 | Docetaxel +/- Suramin in 2nd Line Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 80 | University of Wisconsin, MadisonOTHER | 1 | May 12, 2020 | clinicaltrials |
| NCT00271505 | Avastin/Docetaxel/Carboplatin in Non-Small Cell Lung Cancer | completed | Phase 2 | 43 | M.D. Anderson Cancer CenterOTHER | 1 | May 11, 2020 | clinicaltrials |
| NCT02221739 | Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 39 | NYU Langone HealthOTHER | 1 | May 11, 2020 | clinicaltrials |
| NCT03704870 | Outcomes Following Omission of Daily Routine Chest Radiographs Following Pulmonary Resection | completed | Phase 2 | 50 | University Health Network, TorontoOTHER | 1 | May 1, 2020 | clinicaltrials |
| NCT00080015 | Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC) | completed | Phase 2 | 9 | IpsenINDUSTRY | 0 | Apr 29, 2020 | clinicaltrials |
| NCT02848651 | A Study of Atezolizumab as First-line Monotherapy for Advanced or Metastatic Non-Small Cell Lung Cancer(B-F1RST) | completed | Phase 2 | 153 | Genentech, Inc.INDUSTRY | 1 | Apr 28, 2020 | clinicaltrials |
| NCT00589056 | Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | completed | Phase 1 / Phase 2 | 55 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 24, 2020 | clinicaltrials |
| NCT02336451 | A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients With ALK-positive NSCLC Metastatic to the Brain and/or to Leptomeninges(Ascend-7) | completed | Phase 2 | 156 | Novartis PharmaceuticalsINDUSTRY | 17 | Apr 21, 2020 | clinicaltrials |
| NCT03499834 | A Study to Evaluate the Safety and Efficacy of Ex Vivo Expanded Autologous Immune Killer Cells (IKC) in Stage IV Non-small Cell Lung Cancer (NSCLC) in Patients Who Failed Chemotherapy or Target Therapy(IVY03) | completed | Phase 2 | 26 | Ivy Life Sciences, Co., LtdINDUSTRY | 1 | Apr 16, 2020 | clinicaltrials |
| NCT02573506 | Study of Split-course Chemoradiotherapy For Locally Advanced None-small Cell Lung Cancer | completed | Phase 2 | 99 | Sun Yat-sen UniversityOTHER | 1 | Apr 14, 2020 | clinicaltrials |
| NCT00006229 | Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 774 | NCIC Clinical Trials GroupNETWORK | 14 | Apr 6, 2020 | clinicaltrials |
| NCT00137800 | Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer Patients | completed | Phase 2 | 82 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 3, 2020 | clinicaltrials |
| NCT01773109 | Etirinotecan Pegol (NKTR-102) in NSCLC | completed | Phase 2 | 40 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 3, 2020 | clinicaltrials |
| NCT00436332 | S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma | completed | Phase 2 | 84 | SWOG Cancer Research NetworkNETWORK | 1 | Apr 2, 2020 | clinicaltrials |
| NCT00489008 | SRS Study in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 141 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 30, 2020 | clinicaltrials |
| NCT01876446 | Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer | completed | Phase 2 | 38 | Roswell Park Cancer InstituteOTHER | 1 | Mar 17, 2020 | clinicaltrials |
| NCT02735980 | A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer | completed | Phase 2 | 133 | Eli Lilly and CompanyINDUSTRY | 10 | Mar 17, 2020 | clinicaltrials |
| NCT00792701 | S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer | completed | Phase 2 | 85 | SWOG Cancer Research NetworkNETWORK | 1 | Mar 6, 2020 | clinicaltrials |
| NCT00445848 | S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer | completed | Phase 2 | 89 | SWOG Cancer Research NetworkNETWORK | 1 | Mar 5, 2020 | clinicaltrials |
| NCT00514215 | Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer | completed | Phase 2 | 8 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Mar 5, 2020 | clinicaltrials |
| NCT00960999 | Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer | completed | Phase 2 | 94 | Radiation Therapy Oncology GroupNETWORK | 2 | Mar 4, 2020 | clinicaltrials |
Data updated 24 days agoSource updated Sep 16, 2020source: clinicaltrials